Skip to content
Sign in
Venture capitalBacked 1 network startup

Global Ventures

Dubai VC backing founders in high-growth markets across the Middle East and Africa; led BioSapien's pre-Series A.

Dubai, United Arab Emirates global.vc
Ticket
—Not published
Assets under management
—
Founded
—
Stages
Seedto Series A
Network startups backed
1
Co-investors
1most often with Dara Holdings

How they invest

Founders in markets with large growth potential, with a Middle East and Africa lens; no sector list is published, but the BioSapien lead shows willingness to fund deep-tech health.

Stage and ticket

Seed and Series A; tickets not disclosed. Led a $5.5M pre-Series A.

Geography

Middle East, Africa and Global — MENA and African founders are the core.

What makes them say yes

  • MENA or African company with regional scale ambition
  • Seed/Series A round it can lead
  • Defensible technology or regulated-market moat (e.g., BioSapien)

Red flags

  • No link to the Middle East or Africa
  • Pre-product companies

Sectors

Not published

Stages

  • Seed
  • Series A

Geographies

  • Middle East
  • Africa
  • Global

How to approach

Get a warm intro from BioSapien's founders (Global Ventures led its pre-Series A) and frame the round as a lead opportunity.

Portfolio

1 network startup · no other company

Lead investor in BioSapien (UAE oncology drug delivery) alongside Golden Gate Ventures and Globivest — comfortable leading regulated health deep tech.

Gaps in the portfolio

  • FinTech
  • EdTech
  • AI & software in Africa

Network startups

  • BioSapienSWC 2026 Top 10

    3D-printed biodegradable MediChip implant delivering chemotherapy locally at the tumour site, now in colorectal cancer trials in the UAE.

    United Arab Emirates · Biotech & life sciences

    • pre-Series A · $5.5M · 1 Dec 2024LeadSource

Network startups that fit

4 analysed

Moroccan super-app bundling payments, commerce and everyday services, funded by a record $10M Series A but without public usage metrics.

Moroccan mobile super-app at Series A ($11.4M raised) — North Africa scale story at the stage Global Ventures leads.

55%confidence

Evidence from the records

  • “"Middle East","Africa","Global"”
  • “Mobile super-app (payments, services)”
  • “Super-app launched in Morocco”
Intro path
Founder-to-founder intro via BioSapien (network portfolio company of Global Ventures).
First step
Send a Series A memo through BioSapien's founders.

Egyptian 3D virtual-science-lab platform with an AI lab assistant, claiming 2.5M+ users in 160+ countries after a reported $3M Series A.

Egyptian 3D virtual science labs at Series A — African/MENA edtech with proven traction, an open sector gap for the firm.

50%confidence

Evidence from the records

  • “"Seed","Series A"”
  • “3D virtual science labs”
  • “Claims more than 2.5 million users in more than 160 countries”
Intro path
Founder-to-founder intro via BioSapien (network portfolio company of Global Ventures).
First step
Introduce via Katapult or Sawari Ventures (Praxilabs investors).

Saudi enterprise AI agent that runs workflows across Gmail, Slack, Notion and Jira with role-based controls and Arabic dialect support.

Saudi enterprise AI agent with Arabic task automation — core geography; stage and funding undetermined.

35%confidence

Evidence from the records

  • “Middle East”
  • “Enterprise AI agent (task automation, Arabic)”
  • “No public evidence of traction found (product live with a 14-day free trial, no customer cited).”
Intro path
Founder-to-founder intro via BioSapien (network portfolio company of Global Ventures).
First step
Clarify round size, then request a first call.

Mauritian AI-native healthcare operating system — Eva assistant plus sourced clinical intelligence — sold pay-per-consultation and white-labelled to distributors.

Mauritius primary-care OS with insurer contracts — African healthtech with regulated distribution, echoing the BioSapien appetite for health; self-funded so a first institutional round would be needed.

35%confidence

Evidence from the records

  • “Africa”
  • “Primary care operating system (AI, RAG, EVA agent)”
  • “Contracts signed with the two largest insurers in Mauritius (B2B)”
Intro path
Founder-to-founder intro via BioSapien (network portfolio company of Global Ventures).
First step
Share a seed deck with insurer-contract metrics.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai.

Co-investors

Most often with Dara Holdings

Sources

  1. 1global.vc/about
  2. 2wamda.com/2024/12/uae-based-biotech-biosapien-secures-5-5-million-pre

Profile compiled from public sources. Unknown fields are left empty rather than estimated.